BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23602834)

  • 41. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
    Ashkenazi A
    Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
    Yuan Z; Wang H; Hu Z; Huang Y; Yao F; Sun S; Wu B
    Nutr Cancer; 2015; 67(1):126-36. PubMed ID: 25514492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ASPP and iASPP: Implication in cancer development and progression.
    Li Y; Ahmad A; Sarkar FH
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):2-8. PubMed ID: 26518890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1.
    Yajima T; Ochiai H; Uchiyama T; Takano N; Shibahara T; Azuma T
    Int J Oncol; 2009 Aug; 35(2):273-80. PubMed ID: 19578740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway.
    Yamada S; Sumrejkanchanakij P; Amagasa T; Ikeda MA
    Int J Cancer; 2004 Aug; 111(1):17-22. PubMed ID: 15185338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
    Ponce-Cusi R; Calaf GM
    Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogenes in cell survival and cell death.
    Shortt J; Johnstone RW
    Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23209150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.
    Jain A; Bundela S; Tiwari RP; Bisen PS
    Mol Diagn Ther; 2014 Oct; 18(5):483-94. PubMed ID: 24838674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
    Pisani LP; Estadella D; Ribeiro DA
    Anticancer Res; 2017 Oct; 37(10):5389-5394. PubMed ID: 28982847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.
    Flatt PM; Pietenpol JA
    Drug Metab Rev; 2000; 32(3-4):283-305. PubMed ID: 11139130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.
    Enane FO; Saunthararajah Y; Korc M
    Cell Death Dis; 2018 Sep; 9(9):912. PubMed ID: 30190481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of human papillomavirus and tumor suppressor genes in oral cancer.
    Manvikar V; Kulkarni R; Koneru A; Vanishree M
    J Oral Maxillofac Pathol; 2016; 20(1):106-10. PubMed ID: 27194871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear receptors in oral cancer-Emerging players in tumorigenesis.
    Gangwar SK; Kumar A; Jose S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Cancer Lett; 2022 Jun; 536():215666. PubMed ID: 35364221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy-induced apoptosis in primary tumors.
    McConkey DJ
    Adv Exp Med Biol; 2007; 608():31-51. PubMed ID: 17993231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ID proteins in tumour initiation and progression].
    Pruszko M; Żylicz A
    Postepy Biochem; 2016; 62(4):449-458. PubMed ID: 28132447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.